![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Abbott’s HBV Surface Antigen Test Earns CE Mark
Abbott’s HBV Surface Antigen Test Earns CE Mark
Abbott has been handed the CE Mark for its Determine HBsAg2 diagnostic test, a device used for detecting hepatitis B surface antigens in a patient’s blood.
The portable diagnostic test — which provides results in 15 minutes — can be used with ease in any healthcare setting and has an analytical sensitivity of 0.1 IU/ml.
Patients can provide blood, plasma or serum for the diagnostic test to determine if they are infected with the virus and require treatment.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct